Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Rarecells
Rarecells, Inc. is a healthcare company specializing in early cancer detection through its proprietary ISET® liquid biopsy technology. The company develops and commercializes non-invasive blood tests…
Rarecells
Rarecells, Inc. is a healthcare company specializing in early cancer detection through its proprietary ISET® liquid biopsy technology. The company develops and commercializes non-invasive blood tests…
TL;DR
Core offering: Ultra-early blood-based cancer detection tests using the ISET® circulating tumor cell platform
Founding year: 2010
Headquarters / presence: France (headquartered) with U.S. operations
Funding (reported): $13.0M Series A (Nov 2021) with ~€210K grant in 2018
Patents / publications: Over 49 patents and 125+ scientific publications (company-stated)
